Medical Industry Innovation Institute

Open Course 2023

Medical Industry Innovation Forum
A Special Event

A Special Event is over.

[Theme] Exploring the Future of Drug Discovery in Japan and Around the World


December 5th (Tue) 6:00pm- 8:45 pm (JST) (including optional networking)


Ito International Research Center

Target Audience
200 people
  • Undergraduate and graduate students (from The University of Tokyo and other universities)
  • Medical Innovation Industry Institute members
  • Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
  • Other professionals with a strong interest in leading Innovation in the medical industry
Registration Fee
Course Description

Over the past two decades, the global pharmaceutical market has undergone significant changes. High-priced biopharmaceuticals now dominate top sales,overshadowing Japanese drug discovery, which primarily focuses on small molecule drugs. Japan has found itself sidelined in the race to develop a COVID-19 vaccine, a type of biopharmaceutical, and has had to rely on its own resources. The government has spearheaded efforts to recover from this situation, but the reality is that these efforts are proving to be extremely challenging, with the difficulties seemingly permeating all aspects of Japan’s drug discovery efforts. This forum serves as a gathering place for individuals who remain undeterred by these challenges. These individuals are committed to maximizing the potential of their respective fields through the generous exchange of knowledge, hard work, and financial resources. As we enter a period of significant social and industrial change, this year’s focus will be on the cutting-edge areas that will shape the future of drug discovery. We will also discuss Japan’s role in this field.

Contact Information

Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363


[ A Special Event ] December 5th (Tue) “Venture Innovation in the World and Japann”
Keith Crandell
Co-founder & Managing Director, ARCH Venture Partners
Philippe Fauchet, O.B.E.
Founder, Mirasense Partners / Venture Partner, 4Bio Capital

[Language] English